PLx Pharma (NSDQ:PLXP) announced today that it priced an underwritten public offering worth approximately $63 million. Sparta, N.J.-based PLx Pharma is offering 7.875 million shares of its common stock priced at $8 per share to the public, according to a news release. Additionally, the company granted underwriters a 30-day option to purchase up to more […]
